Billionaire family offices back healthcare and biotech startups in August

The personal investment firms of titans like Stanley Druckenmiller are backing innovations in gene editing, drug discovery and more.

Original reporting by CNBC. GridIndex is an aggregation and intelligence layer — full credit to the original publisher.